MICROCIDE PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: MICROCIDE PHARMACEUTICALS INC, 10-Q, EX-10.31, 2000-08-14
Next: CRESCENT REAL ESTATE EQUITIES LTD PARTNERSHIP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE>                      5
<CIK>                                           0001010915
<NAME>                                          MICROCIDE PHARMACEUTICALS, INC.
<MULTIPLIER>                                    1,000
<CURRENCY>                                      U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                                    DEC-31-2000
<PERIOD-START>                                       APR-1-2000
<PERIOD-END>                                         JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                               4,209
<SECURITIES>                                         14,914
<RECEIVABLES>                                        590
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     20,194
<PP&E>                                               20,197
<DEPRECIATION>                                       (13,486)
<TOTAL-ASSETS>                                       27,826
<CURRENT-LIABILITIES>                                4,737
<BONDS>                                              0
                                0
                                          0
<COMMON>                                             68,010
<OTHER-SE>                                           (46,274)
<TOTAL-LIABILITY-AND-EQUITY>                         27,826
<SALES>                                              0
<TOTAL-REVENUES>                                     1,521
<CGS>                                                0
<TOTAL-COSTS>                                        5,195
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   66
<INCOME-PRETAX>                                      (3,451)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  (3,451)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         (3,451)
<EPS-BASIC>                                          (0.31)
<EPS-DILUTED>                                        (0.31)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission